Chronic Pain in Hansen’s Disease – A Public Health Problem?

Authors

  • Patrick R N A G Stump Instituto Lauro de Souza Lima,
  • Marcos Virmond Instituto Lauro de Souza Lima
  • Rosemari Baccarelli Instituto Lauro de Souza Lima
  • Lúcia H. S. C. Marciano Instituto Lauro de Souza Lima
  • José R. P. Lauris Faculdade de Odontologia de Bauru – USP
  • Somei Ura Instituto Lauro de Souza Lima
  • Manoel Jacobsen Teixeira Faculdade de Medicina da Universidade de São Paulo – FMUSP

Keywords:

chronic pain, neuropatic pain, Hansen’s disease, health attention

Abstract

 Hansen’s disease, which still shows high detection rate in Brazil, features peripheral nerve involvement and skin lesions  with sensory loss. The latter is one of the paradigms to the diagnosis of the disease. However, pain is a symptom that is  being increasingly reported in theses cases. Pain can be nociceptive due to tissue inflammation (reversal reaction and  erythema nodosum leprosum) and neuropatic (due to anatomical and/or functional damage to the nervous system). Fifty  three cases with complaint of pain were studied regarding spatial, temporal, defining, affective and evaluative  characteristics. Among them, 73.6% had completed their MDT/WHO treatment and 84.9% were multibacilary cases.  The spatial localization of pain was more prevalent to the ulnar and tibial nerves. Burning pain was the free description  referred by 28.3% of cases and the affective and evaluative adjectives used reveal a potential interference in the quality  of live of these individuals. Pain in Hansen’s disease cases can be present even after completion of treatment with  sensory, spatial, temporal and affective characteristic that are quite definite and hazardous, which demands control and  proper treatment. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

WHO. World Health Organization. Weekly epidemiological record 2002; 77:1-8.

WHO. World Health Organization. Weekly epidemiological record 2005; 15:113-124.

Hietaharju A, Croft R, Alam R, Birch P, Mong A, Haanpaa M. Chronic neuropathic pain in treated leprosy. Lancet 2000; 356:1080-1.

Stump PRNAG, Baccarelli R, Marciano LHSC, Lauris JRP, Teixeira MJ, Ura S, Virmond MCL. Neuropathic pain in leprosy patients. Int. J. Leprosy 2004; 72:134-138.

Stump PRNAG, Baccarelli R, Marciano LHSC, Lauris JRP, Ura S, Virmond M, Portnoi AG, Okada M, Teixeira MJ. Características da dor crônica na hanseníase. Abstracts Hansen. Int. v.30 (1) 2005, p. 125.

Brasil. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Guia para o Controle da Hanseníase. Brasília, 2002. Cadernos de Atenção Básica; n. 0, série A: Normas e Manuais Técnicos, n.111; 89p.

Max MB, Culnane M, Schafer SC et al. Amitriptyline relieves diabetic neuropathy pain with normal or depressed mood. Neurology 1987;37:589-96 :

Opromolla DVA (Ed). Noções de Hansenologia. Bauru: Centro de Estudos Reynaldo Quagliatto, 2000.

Garbino JA, Nery JA, Virmond M, Stump PRN, Baccarelli R, Marques Jr W. Diagnóstico e tratamento da neuropatia em hanseníase. In: Jatene, F.B. et al. Projeto Diretrizes, volume III. AMB. CFM, Brasília, 2005. p: 147- 159.

Published

2006-12-29

How to Cite

1.
R N A G Stump P, Virmond M, Baccarelli R, H. S. C. Marciano L, R. P. Lauris J, Ura S, Jacobsen Teixeira M. Chronic Pain in Hansen’s Disease – A Public Health Problem?. Bepa [Internet]. 2006 Dec. 29 [cited 2024 May 19];3(36):2-5. Available from: https://periodicos.saude.sp.gov.br/BEPA182/article/view/38774

Issue

Section

Original Article